Clearbridge Investments, LLC Pacira Bio Sciences, Inc. Transaction History

Clearbridge Investments, LLC

$119 Billion
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $733,025 - $938,907	26,463 Added 2.31%	1,172,150 $34.3 Million
Q4 2023 Feb 09, 2024	SELL	$26.32 - $34.31 $99,700 - $129,966	-3,788 Reduced 0.33%	1,145,687 $38.7 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $143,398 - $187,380	-4,674 Reduced 0.4%	1,149,475 $35.3 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $129,345 - $170,097	3,581 Added 0.31%	1,154,149 $46.2 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $325,312 - $397,187	9,156 Added 0.8%	1,150,568 $47 Million
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $377,355 - $567,663	9,881 Added 0.87%	1,141,412 $44.1 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $278,284 - $319,831	5,431 Added 0.48%	1,131,531 $60.2 Million
Q2 2022 Aug 11, 2022	BUY	$51.49 - $81.64 $23,016 - $36,493	447 Added 0.04%	1,126,100 $65.7 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $249,364 - $317,739	4,154 Added 0.37%	1,125,653 $85.9 Million
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $60,777 - $78,820	1,267 Added 0.11%	1,121,499 $67.5 Million
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $174,301 - $195,547	-3,190 Reduced 0.28%	1,120,232 $62.7 Million
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $126,408 - $149,498	2,136 Added 0.19%	1,123,422 $68.2 Million
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $525,783 - $698,739	-8,865 Reduced 0.78%	1,121,286 $78.6 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $196,378 - $257,817	3,891 Added 0.35%	1,130,151 $67.6 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $22,554 - $27,342	434 Added 0.04%	1,126,260 $67.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $69,731 - $118,792	2,264 Added 0.2%	1,125,826 $59.1 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $498,732 - $890,342	-17,561 Reduced 1.54%	1,123,562 $37.7 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $29,156 - $37,604	803 Added 0.07%	1,141,123 $52 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $18,792 - $23,709	527 Added 0.05%	1,140,320 $43.4 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $338,967 - $444,633	-9,269 Reduced 0.81%	1,139,793 $0
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $51,313 - $59,333	1,407 Added 0.12%	1,149,062 $43.7 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $1.14 Million - $1.43 Million	27,503 Added 2.46%	1,147,655 $49.4 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $493,209 - $780,728	15,014 Added 1.36%	1,120,152 $55.1 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $349,882 - $506,375	12,723 Added 1.16%	1,105,138 $35.4 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $25,303 - $39,119	-844 Reduced 0.08%	1,092,415 $34 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $36,277 - $53,476	1,139 Added 0.1%	1,093,259 $49.9 Million
Q3 2017 Nov 14, 2017	SELL	$35.7 - $39.5 $214,985 - $237,869	-6,022 Reduced 0.55%	1,092,120 $41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,098,142	1,098,142 $52.4 Million

Others Institutions Holding PCRX

# of Institutions

301

Shares Held

51.5M

Call Options Held

378K

Put Options Held

1.53M

Black Rock Inc. New York, NY

8.01M
Shares

$116 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.08M
Shares

$73.9 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.16M
Shares

$31.4 Million
0.16% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.07M
Shares

$30 Million
0.1% of portfolio
State Street Corp Boston, MA

1.9M
Shares

$27.7 Million
0.0% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account